Target Price | NZD33.59 |
Price | NZD37.01 |
Deviation |
9.25%
register free of charge
|
Number of Estimates | 15 |
15 Analysts have issued a price target Fisher & Paykel Healthcare Corporation 2025 .
The average Fisher & Paykel Healthcare Corporation target price is NZD33.59.
This is
9.25%
register free of charge
NZD39.20
5.92%
register free of charge
NZD24.81
32.95%
register free of charge
|
|
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Fisher & Paykel Healthcare Corporation stock has an average upside potential 2025 of
9.25%
register free of charge
|
15 Analysts have issued a sales forecast Fisher & Paykel Healthcare Corporation 2025 . The average Fisher & Paykel Healthcare Corporation sales estimate is
This results in the following potential growth metrics:
15 Analysts have issued an Fisher & Paykel Healthcare Corporation EBITDA forecast 2025. The average Fisher & Paykel Healthcare Corporation EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 Fisher & Paykel Healthcare Corporation Analysts have issued a net profit forecast 2025. The average Fisher & Paykel Healthcare Corporation net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Mar '24 |
2025 Estimates |
|
---|---|---|
P/E | 59.88 | |
EV/Sales | 10.93 |
10 Analysts have issued a Fisher & Paykel Healthcare Corporation forecast for earnings per share. The average Fisher & Paykel Healthcare Corporation <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Fisher & Paykel Healthcare Corporation...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.